Clin2
NCT06565845Possibly a fitRecruiting

Comparing treatments for granulomatous lobular mastitis

Granulomatous Mastitis

Part of Skin, Women’s health & pregnancy clinical trials.

This study looks at different ways to treat granulomatous lobular mastitis (GLM), a type of breast inflammation that is not an infection. The goal is to find which treatment works best for people with this condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
350 people
Ages
15 years to 65 years
Study type
Observational

Who can take part

  • You are not currently pregnant or breastfeeding
  • You are between 15 and 65 years old
  • You have been diagnosed with GLM through a biopsy
  • Your liver and kidney function are normal
  • You are not allergic to the antibiotics rifampin, isoniazid, or ethambutol
  • You do not have breast cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07454772Not yet recruiting· Phase 1/Phase 2
Antibiotics vs steroids for granulomatous lobular mastitis

This study compares two common treatments—antibiotics and steroids—to see which works better for a rare breast inflammation condition called granulomatous lobular mastitis (GLM). It aims to find the most effective and safe option for women with this condition.

Bhubaneswar, Odisha
NCT06712524Recruiting
Comparing surgery types for granulomatous mastitis

This study compares different surgical methods for treating granulomatous mastitis, a rare inflammatory breast condition. It aims to find which approach works best for patients who can safely have surgery.

Wuhan, Hubei
NCT07595900Not yet recruiting· Phase 1/Phase 2
Tocilizumab for Hard-to-Treat Breast Inflammation

This trial tests tocilizumab, a medication that reduces inflammation, for granulomatous lobular mastitis (GLM)—a rare, persistent breast inflammation. If your GLM hasn't responded to steroid therapy or you can't tolerate steroids, this study may help reduce inflammation and symptoms.

NCT07422870Not yet recruiting
Registry for granulomatous mastitis

This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.

Düsseldorf, North Rhine-Westphalia
NCT04637711Recruiting
Surgery for stubborn granulomatous breast inflammation

This study looks at surgical treatment for granulomatous lobular mastitis that has not been improving with non-surgical care. It may help people with more widespread or complicated breast inflammation, especially when there are abscesses or skin breakdown.

Wuhan, Hubei
NCT05395949Enrolling by invitation
Treat breast inflammation with support for mental health

This study looks at a non-surgical (“conservative”) approach to treating granulomatous lobular mastitis, along with help for mental health symptoms. It may help people whose breast inflammation and mental health concerns happen together.

Wuhan, Hubei

Hear when a new Granulomatous Mastitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.